Preladenant, a selective adenosine A2A receptor antagonist, is not associated with QT/QTc prolongation

Published 2013 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Preladenant, a selective adenosine A2A receptor antagonist, is not associated with QT/QTc prolongation
Authors
Keywords
Preladenant, Adenosine A<sub>2A</sub> receptor antagonist, Thorough QT/QTc study, Parkinson’s disease
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 69, Issue 10, Pages 1761-1767
Publisher
Springer Nature
Online
2013-07-15
DOI
10.1007/s00228-013-1541-5
References
View 3 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.